Global In-vitro Diagnostics Enzymes Market Size & Outlook
Global in-vitro diagnostics enzymes market, 2018-2030 (US$M)
Global in-vitro diagnostics enzymes market highlights
- The global in-vitro diagnostics enzymes market generated a revenue of USD 2,179.8 million in 2023 and is expected to reach USD 3,699.7 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 7.9% by 2030.
- In terms of segment, proteases accounted for a revenue of USD 2,179.8 million in 2023.
- Proteases is the most lucrative enzyme type segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2023.
Global data book summary
| Market revenue in 2023 | USD 2,179.8 million |
| Market revenue in 2030 | USD 3,699.7 million |
| Growth rate | 7.9% (CAGR from 2023 to 2030) |
| Largest segment | Proteases |
| Fastest growing segment | Proteases |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Proteases |
Other key industry trends
- In terms of revenue, the North America accounted for 41.7% of the global in-vitro diagnostics enzymes market in 2023.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
In-vitro Diagnostics Enzymes Market Scope
In-vitro Diagnostics Enzymes Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global in-vitro diagnostics enzymes market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in-vitro diagnostics enzymes market will help companies and investors design strategic landscapes.
Proteases was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Global in-vitro diagnostics enzymes market based on proteases covering the revenue growth of each sub-segment from 2018 to 2030.
- Global In-vitro Diagnostics Enzymes Enzyme Type Outlook (Revenue, USD Million, 2018-2030)
- Proteases
- Therapeutic Area
- Infectious disease
- Diabetes
- Oncology
- Cardiology
- Nephrology
- Autoimmune diseases
- Others
- Technology Use
- Histology Assays
- Molecular Diagnostics
- PCR Assays
- NGS Assays
- Others
- Clinical Chemistry
- Physical Form
- Powder
- Liquid
- Type
- Natural
- Recombinant
- End Use
- Pharma & Biotech
- Hospital & Diagnostic Labs
- CROs
- Academic Labs
- Therapeutic Area
- Polymerase & Transcriptase
- Ribonuclease
- Others
- Proteases
- Global In-vitro Diagnostics Enzymes Therapeutic Area Outlook (Revenue, USD Million, 2018-2030)
- Infectious disease
- COVID-19 Testing
- Hepatitis
- HIV
- Others
- Diabetes
- Oncology
- Cardiology
- Nephrology
- Autoimmune diseases
- Others
- Infectious disease
- Global In-vitro Diagnostics Enzymes Technology Type Outlook (Revenue, USD Million, 2018-2030)
- Histology Assays
- Molecular Diagnostics
- PCR Assays
- NGS Assays
- Others
- Clinical Chemistry
- Global In-vitro Diagnostics Enzymes End Use Outlook (Revenue, USD Million, 2018-2030)
- Pharma & Biotech
- Hospital & Diagnostic Labs
- CROs
- Academic Labs
Reasons to subscribe to Global in-vitro diagnostics enzymes market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global in-vitro diagnostics enzymes market databook
-
Our clientele includes a mix of in-vitro diagnostics enzymes market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global in-vitro diagnostics enzymes market, including forecasts for subscribers. This global databook contains high-level insights into Global in-vitro diagnostics enzymes market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global in vitro diagnostics enzymes market size, by regions, 2018-2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
